Absolute Antibody Offers SARS-CoV-2 Neutralizing Antibodies Derived from COVID-19 Patients

REDCAR, UNITED KINGDOM - Aug 18, 2020 - Absolute Antibody Ltd., an industry-leading provider of recombinant antibody products and services, today announced the availability of SARS-CoV-2 neutralizing antibodies derived from individuals infected with COVID-19

Kyruus Launches Online Consumer Scheduling for Virtual Care Visits

BOSTON, MA, UNITED STATES - Aug 18, 2020 - Kyruus, the leader in provider search and scheduling solutions for health systems, today announced the availability of online scheduling for virtual care visits within its Kyruus ProviderMatch® for Consumers solution for health system websites

Abzena appoints Anu Bansal Ph.D. as Senior Director of Manufacturing at Bristol, Pennsylvania facility

BRISTOL, PA - Aug 18, 2020 - Cambridge, UK and San Diego, CA, 18 August 2020 - Abzena, a leading Partner Research Organization (PRO) for biopharmaceutical outsourced solutions from concept to clinic and into GMP manufacturing has announced the appointment of Anu Bansal as Senior Director of Manufacturing at its facility in Bristol, Pennsylvania

BOC Sciences Launches Its Amino Acids Subsite

SHIRLEY, NY - Aug 18, 2020 - As a global Contract Research Organization (CRO), BOC Sciences has served the pharmaceutical and biotechnology industries for over a decade, and has provided an extensive catalog of amino acids, peptides and resins for laboratory and scientific applications

Creative Biolabs’ Oncolytic Virus Construction Services Help to Shape the Future of Oncolytic Virotherapy

SHIRLEY, NY, UNITED STATES - Aug 18, 2020 - Oncolytic viruses (OVs), evolved and engineered for cancer specificity, are gaining momentum as a new drug class in the fight against cancer

Creative Diagnostics Offers High-quality Magnetic Silica Particles for DNA & RNA Isolation

SHIRLEY, NY, UNITED STATES - Aug 14, 2020 - Nucleic acid extraction (NAE) plays a vital role in molecular biology as the primary step for many downstream applications

THREAD Accelerates Expansion to Advance Global Decentralized Clinical Trials

DURHAM, NC, UNITED STATES - Aug 13, 2020 - THREAD, an innovative technology and service provider that enables decentralized clinical research, announced today that it’s accelerating the company’s expansion after receiving an additional capital commitment of up to $50 million from strategic health care investors, Water Street Healthcare Partners and JLL Partners

Almac Clinical Services Launches Virtual Auditing Solution for Clients

CRAIGAVON, NORTHERN IRELAND - Aug 11, 2020 -  Almac Clinical Services has digitised its conventional on-site auditing process and launched a virtual auditing solution for clients

MDI Biological Laboratory Hosts 2020 National Science Foundation Fellows

BAR HARBOR, ME, UNITED STATES - Aug 11, 2020 - BAR HARBOR, MAINE -- Six undergraduates from throughout the country studied at the MDI Biological Laboratory this summer under a Research Experiences for Undergraduates (REU) grant from the National Science Foundation (NSF) whose goal was to engage students "in meaningful ways" in ongoing research projects

Medicaid Transformation Project Releases Phase One Report

CHICAGO, IL, UNITED STATES - Aug 11, 2020 - Today, the Medicaid Transformation Project (MTP) announced the release of its Phase One Report, which summarizes the results of its first two years of work

CD Genomics Launches Complete Product Portfolio for Research to COVID-19 Response

SHIRLEY, NY, UNITED STATES - Aug 17, 2020 - CD Genomics is a genomics service company with good reputation in providing reliable microbial sampling products, microbial testing services, microbial genomics services, and integrated bioinformatics services

CD Genomics Announces Advanced CDAMP® Panel Kits for SARS-CoV-2 Detection

SHIRLEY, NY, UNITED STATES - Aug 12, 2020 - CD Genomics, an internationally leading provider of microbial testing services, microbial genomics services, and integrated bioinformatics services for hospitals, food, diagnostics, pharma, agriculture, biotechnology, and research institutes, announces advanced CDAMP® Panel Kits for SARS-CoV-2 detection

Creative Proteomics Introduces Advanced Gut Metatranscriptome Analysis Solutions

SHIRLEY, NY, UNITED STATES - Aug 10, 2020 - Creative Proteomics, an integrated CRO company committed to providing oncology multi-omics research services and personalized custom oncology research services, has recently launched its fully-developed gut metatranscriptome analysis solutions for the identification of key genes and gut physiology monitoring, as well as clinical diagnosis and screening for drug targets or for genes, enzymes and metabolites relevant for human health

Creative Enzymes Optimizes Screening of Enzyme Activators for Enzyme Profiling

SHIRLEY, NY, UNITED STATES - Aug 10, 2020 - Creative Enzymes, an excellent supplier and manufacturer located in New York, always hammers at researches and trials in order to provide customers with various enzymes as many as possible

Kyruus Recruits Jamie Kiggen as its New Chief Financial Officer

BOSTON, MA, UNITED STATES - Aug 6, 2020 - Kyruus, the leader in provider search and scheduling solutions for health systems, today announced that Jamie Kiggen has joined its executive leadership team as Chief Financial Officer

Phesi Powers Data-Driven Clinical Trials Through Addition of New Country Selection Functionality to ClinSite

CONNECTICUT, CT, UNITED STATES - Aug 6, 2020 - Phesi, a data-driven provider of clinical development analytics products and solutions, today announced a new country selection functionality has been added to ClinSite, its platform to provide investigator site intelligence to clients, enabling investigator site selection and management

Over 300 Clinical Studies Benefit from CluePoints COVID-19 Risk Management Support

KING OF PRUSSIA, PA - Aug 6, 2020 - CluePoints, the premier provider of Risk-Based Study Execution (RBx) and Data Quality Oversight Software for clinical trials, today announced the success of its complimentary COVID-19 risk management package alongside comprehensive support for COVID-19 affected trials

Raremark® launches the Xperiome™ patient-powered knowledge platform to deliver new therapies faster and smarter

LONDON, UK - Aug 6, 2020 - Raremark®, the leading online patient community in rare disease, has today launched its patient-powered knowledge platform Xperiome™ to help the pharmaceutical industry deliver innovative new therapies faster and smarter

Panthera’s UK oncology clinical trial sites open for studies

PRESTON, UNITED KINGDOM - Aug 3, 2020 -  

• More than 1000 International Cancer Trials Suspended Due to COVID-19 

• Panthera working with the state of the art  Rutherford Cancer Centres across the UK  is open for clinical research activities including screening

Sterling Signs Deal to Produce Potential COVID-19 Drug Candidate for Moleculin

CRAMLINGTON, UNITED KINGDOM - Jul 27, 2020 - Global contract development and manufacturing organisation (CDMO), Sterling Pharma Solutions has signed an agreement with Moleculin Biotech, Inc